Mobile

A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Single and Multiple Oral Dose Administration of BIIB014 in Subjects with Moderate to Late Stage Parkinson’s Disease Who Are Als...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-003490-27

A Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study of Single and Multiple Oral Dose Administration of BIIB014 in Subjects with Moderate to Late Stage Parkinson’s Disease Who Are Also Receiving Treatment with Levodopa

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to assess the preliminary safety and tolerability of single and multiple oral doses of BIIB014 when administered as adjunct therapy in subjects with moderate to late-stage PD who are also receiving L-DOPA.

Critère d'inclusion

  • Parkinson's disease

Liens